NCT06166836 2026-03-25a Study to Evaluate the Safety and Efficacy of D-1553 Combined With IN10018 in KRAS G12C Mutant Solid TumorsInxMed (Shanghai) Co., Ltd.Phase 1/2 Active not recruiting140 enrolled